Reviewing Taiwan Liposome Company Ltd. (TLC)’s and Intec Pharma Ltd. (NASDAQ:NTEC)’s results

Taiwan Liposome Company Ltd. (NASDAQ:TLC) and Intec Pharma Ltd. (NASDAQ:NTEC) are two firms in the Biotechnology that compete against each other. Below is a comparison of their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation.

Earnings and Valuation

We can see in table 1 the earnings per share (EPS), gross revenue and valuation of Taiwan Liposome Company Ltd. and Intec Pharma Ltd.

Profitability

Table 2 shows us the return on assets, net margins and return on equity of both companies.

Institutional Insider Ownership

Roughly 2.46% of Taiwan Liposome Company Ltd. shares are owned by institutional investors while 39.64% of Intec Pharma Ltd. are owned by institutional investors. Comparatively, 11.81% are Intec Pharma Ltd.’s share owned by insiders.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

For the past

... read more at: https://hinewulm.com/2019/03/13/reviewing-taiwan-liposome-company-ltd-tlcs-and-intec-pharma-ltd-nasdaqntecs-results/

by

Leave a Reply